Answer
Dacomitinib monohydrate (Vizimpro) should not be used during pregnancy because its mechanism of action indicates that it may cause foetal harm, and there are no data on its use in pregnant women.
Sources for this answer
- Vizimpro 15mg film-coated tabletsPfizer Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 5Document updated
Sources checked